Skip to search.
 TSX Down 0.18% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS

19.59 Up 0.15(0.77%) 12:17PM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:19.44
Open:19.42
Bid:19.55 x 300
Ask:19.56 x 200
1y Target Est:27.95
Beta:1.32
Next Earnings Date:29-Jul-13ARIA Earnings announcement
Day's Range:19.09 - 19.64
52wk Range:15.13 - 25.40
Volume:1,311,446
Avg Vol (3m):3,137,110
Market Cap:3.62B
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
ARIAUp 0.77%3.62B
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.59%11.96B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):517.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-1.67
Quarterly EPS Est (Jun-13) :-0.40
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing addition... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback